search octane
Kingston, Ontario, January 2, 2024 – The Octane Medical Group is pleased to announce that the contract development and manufacturing arm of its German subsidiary TETEC AG is now Octane CDMO, an expanded operation with the know-how, years of experience, technology, systems and international network to drive complex, personalized cell therapies from concept to commercialization.
January 2, 2025
Kingston, Ontario, Canada / Melsungen, Germany, June 5th, 2024 – Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition, consisting of the two companies TETEC AG in Germany and Aesculap Biologics, LLC. in the United States, establishes Octane as an international leader in regenerative medicine.
June 5, 2024
Kingston, Ontario, June 2, 2022 – Octane Exo Inc., an Octane Medical Group venture, has achieved a breakthrough in medical implant technology with Octane HyperPEEK, an advanced biocomposite proven to enhance bone regeneration with the goal of enhanced integration and stability.
March 2, 2022
Kingston, Ontario, May 2012 – Octane Medical Group has entered into a partnership with Aesculap Biologics, LLC, a subsidiary of the multinational Aesculap Inc., (a B. Braun company) one of the world’s largest orthopedic companies with a focus on innovative spine and orthopedic treatments. The partnership is an ...
March 12, 2012
Kingston, Ontario, October 2014 – Octane Medical Group has established a collaboration with Jubilant DraxImage Inc., a subsidiary of the multinational Jubilant Life Sciences in Uttar Pradesh, India, to develop and produce radioisotope patient infusion lines for RUBY-FILL, the most advanced Positron Emission Tomography (PET) delivery system for ...
October 10, 2014
